Need some 2020 drug pricing intel? We’ve got you covered...
As my colleague Lev puts it, “there is no best-case scenario for the drug industry in 2020.” So, if you’re in the drug industry, you should probably be bracing for impact. The first step, of course, is figuring out what the heck all of these candidates want to do. And for that, I present to you a new report from STAT, which does just that: Outlines the drug pricing plans of every 2020 presidential candidate.
And let me tell you, the report is thorough: If anyone from Marianne Williamson to Joe Biden has ever said anything about drug pricing, Lev has got you covered. Did you know, for example, that Andrew Yang supports Elizabeth Warren’s idea of getting the government into the generic manufacturing business, but really doesn’t like importation? I bet you didn’t...
Check out a sample of the report, here. And I’d encourage you to make the jump and read the whole report, which can be found here.
And let me tell you, the report is thorough: If anyone from Marianne Williamson to Joe Biden has ever said anything about drug pricing, Lev has got you covered. Did you know, for example, that Andrew Yang supports Elizabeth Warren’s idea of getting the government into the generic manufacturing business, but really doesn’t like importation? I bet you didn’t...
Check out a sample of the report, here. And I’d encourage you to make the jump and read the whole report, which can be found here.
No hay comentarios:
Publicar un comentario